Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Beam Therapeutics Inc BEAM

Healthcare Biotechnology
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead... see more

Recent & Breaking News (NDAQ:BEAM)

Beam Therapeutics to Participate at the Wells Fargo 2022 Healthcare Conference

GlobeNewswire September 1, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

Newsfile August 12, 2022

ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox

GlobeNewswire August 11, 2022

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 11, 2022

Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results

GlobeNewswire August 9, 2022

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 8, 2022

ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 4, 2022

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Business Wire August 3, 2022

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 3, 2022

Beam Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference

GlobeNewswire August 2, 2022

Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application

GlobeNewswire August 1, 2022

Beam Therapeutics to Present First Research Highlighting Approach to Develop Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant

GlobeNewswire June 27, 2022

Beam Therapeutics to Participate in the 2022 Jefferies Healthcare Conference

GlobeNewswire June 3, 2022

Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results

GlobeNewswire May 9, 2022

Beam Therapeutics to Participate in Upcoming May Investor Conferences

GlobeNewswire May 4, 2022

Beam Therapeutics to Present New Preclinical Data from Base Editing Pipeline at ASGCT 25th Annual Meeting

GlobeNewswire May 2, 2022

Beam Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Conference

GlobeNewswire March 25, 2022

Beam Therapeutics to Participate in the Barclays 2022 Global Healthcare Conference

GlobeNewswire March 8, 2022

Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire February 28, 2022

Beam Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference

GlobeNewswire February 9, 2022